Published in Int J Alzheimers Dis on January 13, 2011
Binding of the molecular chaperone αB-crystallin to Aβ amyloid fibrils inhibits fibril elongation. Biophys J (2011) 1.16
Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism. PLoS One (2012) 0.85
Truncated tau deregulates synaptic markers in rat model for human tauopathy. Front Cell Neurosci (2015) 0.77
Brain Cholesterol Metabolism and Its Defects: Linkage to Neurodegenerative Diseases and Synaptic Dysfunction. Acta Naturae (2016) 0.77
Europium as an inhibitor of Amyloid-β(1-42) induced membrane permeation. FEBS Lett (2015) 0.76
Cholesterol in the Pathogenesis of Alzheimer's, Parkinson's Diseases and Autism: Link to Synaptic Dysfunction. Acta Naturae (2017) 0.75
Toxic species in amyloid disorders: Oligomers or mature fibrils. Ann Indian Acad Neurol (2015) 0.75
Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature (2002) 19.36
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science (2003) 18.18
A specific amyloid-beta protein assembly in the brain impairs memory. Nature (2006) 16.19
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Alzheimer's disease: the amyloid cascade hypothesis. Science (1992) 13.80
Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell (1993) 10.15
Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature (1992) 7.02
Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron (1994) 6.41
Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem (2002) 5.63
Rapid induction of Alzheimer A beta amyloid formation by zinc. Science (1994) 5.34
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem (2005) 4.23
An analytical solution to the kinetics of breakable filament assembly. Science (2009) 3.87
Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci (2004) 3.59
Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis (2000) 3.46
Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J Neurochem (2005) 3.06
Self-assembly of Abeta(1-42) into globular neurotoxins. Biochemistry (2003) 2.85
GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat Med (1995) 2.77
Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci (2006) 2.47
Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc Natl Acad Sci U S A (2003) 2.33
Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc Natl Acad Sci U S A (2008) 2.25
Thermodynamics of A beta(1-40) amyloid fibril elongation. Biochemistry (2005) 1.81
Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry (2002) 1.56
Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem (2004) 1.55
Insights into the amyloid folding problem from solid-state NMR. Biochemistry (2003) 1.54
Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains. J Biol Chem (2009) 1.52
ANS binding reveals common features of cytotoxic amyloid species. ACS Chem Biol (2010) 1.48
A seed for Alzheimer amyloid in the brain. J Neurosci (2004) 1.45
Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem (2001) 1.44
Characterization of neuronal dystrophy induced by fibrillar amyloid beta: implications for Alzheimer's disease. Neuroscience (2002) 1.31
A fluid connection: cholesterol and Abeta. Proc Natl Acad Sci U S A (2001) 1.22
Abeta polymerization through interaction with membrane gangliosides. Biochim Biophys Acta (2010) 1.21
Physicochemical interactions of amyloid beta-peptide with lipid bilayers. Biochim Biophys Acta (2007) 1.15
Interactions of amyloid beta-peptide (1-40) with ganglioside-containing membranes. Biochemistry (1999) 1.14
Alzheimer's disease: treatments in discovery and development. Nat Neurosci (2002) 1.06
Increasing age alters transbilayer fluidity and cholesterol asymmetry in synaptic plasma membranes of mice. J Neurochem (1996) 1.05
Increased cholesterol in Abeta-positive nerve terminals from Alzheimer's disease cortex. Neurobiol Aging (2005) 1.01
Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev (2001) 1.01
Structural transitions associated with the interaction of Alzheimer beta-amyloid peptides with gangliosides. J Biol Chem (1998) 0.98
Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid beta-protein fibrillogenesis. Biochim Biophys Acta (2008) 0.96
A ganglioside-induced toxic soluble Abeta assembly. Its enhanced formation from Abeta bearing the Arctic mutation. J Biol Chem (2006) 0.96
Formation of toxic Abeta(1-40) fibrils on GM1 ganglioside-containing membranes mimicking lipid rafts: polymorphisms in Abeta(1-40) fibrils. J Mol Biol (2008) 0.95
GM1 ganglioside-mediated accumulation of amyloid beta-protein on cell membranes. Biochem Biophys Res Commun (2005) 0.94
Inhibitors of amyloid beta-protein aggregation mediated by GM1-containing raft-like membranes. Biochim Biophys Acta (2006) 0.93
Formation of amyloids by Abeta-(1-42) on NGF-differentiated PC12 cells: roles of gangliosides and cholesterol. J Mol Biol (2007) 0.92
Alzheimer's disease. Bad for the heart, bad for the mind? Science (2001) 0.90
Driving force of binding of amyloid beta-protein to lipid bilayers. Biochem Biophys Res Commun (2008) 0.88
Late endocytic dysfunction as a putative cause of amyloid fibril formation in Alzheimer's disease. J Neurochem (2009) 0.88
Cholesterol is increased in the exofacial leaflet of synaptic plasma membranes of human apolipoprotein E4 knock-in mice. Neuroreport (2002) 0.87
Two distinct conformations of Abeta aggregates on the surface of living PC12 cells. Biophys J (2009) 0.87
Interaction between amyloid beta-protein aggregates and membranes. J Pept Sci (2004) 0.85
Ganglioside-mediated aggregation of amyloid β-proteins (Aβ): comparison between Aβ-(1-42) and Aβ-(1-40). J Neurochem (2011) 0.84
Amyloid beta-protein and lipid metabolism. Biochim Biophys Acta (2007) 0.80